On this view, the patients with larger tumors had more aggressive tumor biology (accompanied by higher serum AFP levels and increased percent of patients with PVT) and their shorter survival may thus have been predicated on their more aggressive tumor biology, which resulted in those patients having tumors that grew beyond the transplant criteria. This evidence concerns the gene AFP and neoplasm.